332 related articles for article (PubMed ID: 33951726)
21. Mutations of the transcription factor PU.1 are not associated with acute lymphoblastic leukaemia.
Mueller BU; Pabst T; Hauser P; Neuberg D; Tenen DG
Br J Cancer; 2006 Jun; 94(12):1918-20. PubMed ID: 16735999
[TBL] [Abstract][Full Text] [Related]
22. Global changes in the nuclear positioning of genes and intra- and interdomain genomic interactions that orchestrate B cell fate.
Lin YC; Benner C; Mansson R; Heinz S; Miyazaki K; Miyazaki M; Chandra V; Bossen C; Glass CK; Murre C
Nat Immunol; 2012 Dec; 13(12):1196-204. PubMed ID: 23064439
[TBL] [Abstract][Full Text] [Related]
23. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors.
Scott EW; Fisher RC; Olson MC; Kehrli EW; Simon MC; Singh H
Immunity; 1997 Apr; 6(4):437-47. PubMed ID: 9133423
[TBL] [Abstract][Full Text] [Related]
24. Myeloid development is selectively disrupted in PU.1 null mice.
Anderson KL; Smith KA; Conners K; McKercher SR; Maki RA; Torbett BE
Blood; 1998 May; 91(10):3702-10. PubMed ID: 9573007
[TBL] [Abstract][Full Text] [Related]
25. Visualizing PU.1 activity during hematopoiesis.
Back J; Allman D; Chan S; Kastner P
Exp Hematol; 2005 Apr; 33(4):395-402. PubMed ID: 15781329
[TBL] [Abstract][Full Text] [Related]
26. Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality.
Houston IB; Kamath MB; Schweitzer BL; Chlon TM; DeKoter RP
Exp Hematol; 2007 Jul; 35(7):1056-68. PubMed ID: 17588474
[TBL] [Abstract][Full Text] [Related]
27. Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members.
Müller S; Sideras P; Smith CI; Xanthopoulos KG
Oncogene; 1996 Nov; 13(9):1955-64. PubMed ID: 8934542
[TBL] [Abstract][Full Text] [Related]
28. EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription.
Ayoub E; Wilson MP; McGrath KE; Li AJ; Frisch BJ; Palis J; Calvi LM; Zhang Y; Perkins AS
Nat Commun; 2018 Oct; 9(1):4239. PubMed ID: 30315161
[TBL] [Abstract][Full Text] [Related]
29. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
Gangenahalli GU; Gupta P; Saluja D; Verma YK; Kishore V; Chandra R; Sharma RK; Ravindranath T
Stem Cells Dev; 2005 Apr; 14(2):140-52. PubMed ID: 15910240
[TBL] [Abstract][Full Text] [Related]
30. A somatic mutation of GFI1B identified in leukemia alters cell fate via a SPI1 (PU.1) centered genetic regulatory network.
Anguita E; Gupta R; Olariu V; Valk PJ; Peterson C; Delwel R; Enver T
Dev Biol; 2016 Mar; 411(2):277-286. PubMed ID: 26851695
[TBL] [Abstract][Full Text] [Related]
31. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages.
Arinobu Y; Mizuno S; Chong Y; Shigematsu H; Iino T; Iwasaki H; Graf T; Mayfield R; Chan S; Kastner P; Akashi K
Cell Stem Cell; 2007 Oct; 1(4):416-27. PubMed ID: 18371378
[TBL] [Abstract][Full Text] [Related]
32. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors.
DeKoter RP; Walsh JC; Singh H
EMBO J; 1998 Aug; 17(15):4456-68. PubMed ID: 9687512
[TBL] [Abstract][Full Text] [Related]
33. Blood stem cell PU.1 upregulation is a consequence of differentiation without fast autoregulation.
Ahmed N; Etzrodt M; Dettinger P; Kull T; Loeffler D; Hoppe PS; Chavez JS; Zhang Y; Camargo Ortega G; Hilsenbeck O; Nakajima H; Pietras EM; Schroeder T
J Exp Med; 2022 Jan; 219(1):. PubMed ID: 34817548
[TBL] [Abstract][Full Text] [Related]
34. Single-cell analyses of regulatory network perturbations using enhancer-targeting TALEs suggest novel roles for PU.1 during haematopoietic specification.
Wilkinson AC; Kawata VK; Schütte J; Gao X; Antoniou S; Baumann C; Woodhouse S; Hannah R; Tanaka Y; Swiers G; Moignard V; Fisher J; Hidetoshi S; Tijssen MR; de Bruijn MF; Liu P; Göttgens B
Development; 2014 Oct; 141(20):4018-30. PubMed ID: 25252941
[TBL] [Abstract][Full Text] [Related]
35. Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
Gu X; Hu Z; Ebrahem Q; Crabb JS; Mahfouz RZ; Radivoyevitch T; Crabb JW; Saunthararajah Y
J Biol Chem; 2014 May; 289(21):14881-95. PubMed ID: 24695740
[TBL] [Abstract][Full Text] [Related]
36. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1.
Rosenbauer F; Owens BM; Yu L; Tumang JR; Steidl U; Kutok JL; Clayton LK; Wagner K; Scheller M; Iwasaki H; Liu C; Hackanson B; Akashi K; Leutz A; Rothstein TL; Plass C; Tenen DG
Nat Genet; 2006 Jan; 38(1):27-37. PubMed ID: 16311598
[TBL] [Abstract][Full Text] [Related]
37. EVI1 Impairs myelopoiesis by deregulation of PU.1 function.
Laricchia-Robbio L; Premanand K; Rinaldi CR; Nucifora G
Cancer Res; 2009 Feb; 69(4):1633-42. PubMed ID: 19208846
[TBL] [Abstract][Full Text] [Related]
38. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation.
Iwasaki H; Somoza C; Shigematsu H; Duprez EA; Iwasaki-Arai J; Mizuno S; Arinobu Y; Geary K; Zhang P; Dayaram T; Fenyus ML; Elf S; Chan S; Kastner P; Huettner CS; Murray R; Tenen DG; Akashi K
Blood; 2005 Sep; 106(5):1590-600. PubMed ID: 15914556
[TBL] [Abstract][Full Text] [Related]
39. Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter.
Chen H; Zhang P; Radomska HS; Hetherington CJ; Zhang DE; Tenen DG
J Biol Chem; 1996 Jun; 271(26):15743-52. PubMed ID: 8663022
[TBL] [Abstract][Full Text] [Related]
40. Dose-dependent repression of T-cell and natural killer cell genes by PU.1 enforces myeloid and B-cell identity.
Kamath MB; Houston IB; Janovski AJ; Zhu X; Gowrisankar S; Jegga AG; DeKoter RP
Leukemia; 2008 Jun; 22(6):1214-25. PubMed ID: 18354487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
